Wednesday, February 28, 2024

      Subscribe Now!


Lankenau Heart Institute at Paoli Hospital has Implanted the Region’s First MRI-Safe...

Lankenau Heart Institute at Paoli Hospital has Implanted the Region’s First MRI-Safe Cardiac Resynchronization Defibrillator

Hellenic News
Hellenic News
The copyrights for these articles are owned by HNA. They may not be redistributed without the permission of the owner. The opinions expressed by our authors do not necessarily reflect the opinions of HNA and its representatives.

Latest articles


Patients with Serious Heart Conditions Can Now Safely Undergo Full-Body MRI Scans


(April 8, 2016, Paoli, PA) – Lankenau Heart Institute at Paoli Hospital, part of Main Line Health, is the first in the Philadelphia region to implant a cardiac resynchronization therapy defibrillator (CRT-Ds) approved by the FDA for use with magnetic resonance imaging (MRI) scans. CRT devices are designed to help the heart pump more effectively in a coordinated rhythm, decreasing heart failure symptoms and helping to reduce the risk of sudden cardiac arrest. Until now, however, patients with CRT-Ds have not been able to receive MRI scans because of the potential for harmful interaction between the MRI and the device. With as many as 40 percent of CRT patients meeting an indication for an MRI within four years of receiving a device, thousands of patients implanted with CRT-Ds have not had access to MRI scans when needed.


Thanks for reading Hellenic News of America

“Our cardiac team is excited to be leading the way in improving care for heart failure patients,” said Matthew Goldstein, MD, electrophysiologist at Paoli Hospital. “Cardiac resynchronization therapy is a vital treatment option for heart failure patients, and has been shown to improve quality of life. Patients being treated for heart failure with these new MR-conditional CRT-D devices will no longer be denied access to MRI scans, which can be critical for doctors to detect and treat other underlying, potentially life-threatening conditions.”


“This novel and valuable advance in pacemaker technology serves as another example of how the Lankenau Heart Institute team collaborates to provide advanced cardiac treatment to improve the lives of our patients,” says William Gray, System Chief of the Division of Cardiovascular Disease at Main Line Health and President of Lankenau Heart Institute. “We look forward to continuing to deliver the latest technological advances to those patients requiring treatment at Lankenau Heart Institute locations throughout the region as part of our commitment to provide superior heart care.”


One million people with heart failure are hospitalized each year in the U.S., and 25 percent of them will be re-hospitalized within 30 days. Chronic heart failure occurs when the heart is unable to pump enough blood to sustain adequate circulation in the body’s tissues. CRT is a cost-effective and beneficial therapy for appropriate patients, helping the heart to effectively pump blood and oxygen to the body, reducing the risk of death and offering improvements in quality of life for heart failure patients.


Allowing for MRI scans on any part of the body without positioning restrictions, the MRI-conditional CRT-Ds from Medtronic are designed to optimize therapy delivery. Amplia MRI features the AdaptivCRT® algorithm, reducing a patient’s odds of a heart failure readmission within 30 days by 59 percent, and reducing the risk of atrial fibrillation by 46 percent.


For more information about the MRI-conditional CRT-Ds, please visit or call 1-866-CALL-MLH.


About Paoli Hospital

Paoli Hospital, a member of Main Line Health, is a 231-bed, not-for-profit acute care hospital and Regional Trauma Center with outpatient facilities in Exton and Collegeville. Paoli has been ranked among the top 10 hospitals in the Philadelphia Metro area by U.S. News & World Report’s “Best Hospital” rankings for excellence in the care of patients with COPD and heart failure. Paoli is a multi-year recipient of the Premier “Award for Quality” and Truven Health Analytics’ 100 Top Hospitals® for providing superior patient care, and has earned Magnet® designation for the third time for its superior nursing staff. For more information about Paoli Hospital, visit


About Lankenau Heart Institute

Lankenau Heart Institute is Main Line Health’s premier, comprehensive cardiovascular medicine and surgery program. Lankenau Heart Institute brings together the clinical expertise of all four of Main Line Health’s acute care hospitals and community cardiology practices to ensure that patients receive a level of quality, service and experience that is unprecedented in the region. Through the Systemwide coordination of services, Lankenau Heart Institute delivers preventive, diagnostic, therapeutic and rehabilitative cardiovascular services at each of our locations, including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.


With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained nurses and technologists, the Lankenau Heart Institute is dedicated to managing and treating patients with heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.

The copyrights for these articles are owned by the Hellenic News of America. They may not be redistributed without the permission of the owner. The opinions expressed by our authors do not necessarily reflect the opinions of the Hellenic News of America and its representatives.

Get Access Now!